您的位置: 首页 > 农业专利 > 详情页

PROMOTION DE LA TRANSFORMATION DE NF-KAPPAB1 P105 EN P50 PAR L'UBIQUITINE LIGASE KPC1, DÉCLENCHANT UN FORT EFFET ANTITUMORAL
专利权人:
RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
发明人:
CIECHANOVER, Aaron,KRAVTSOVA, Yelena,SHOMER, Inna,COHEN, Victoria
申请号:
EP16739877
公开号:
EP3265112A4
申请日:
2016.01.05
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The invention provides a method for treating cancer comprising the step of administering a therapeutically effective amount of KPC1, a peptide which is at least about 70% homologous to the KPC1 or an agent which up-regulates KPC1. In some embodiments, there is also provided a method for treating cancer comprising the step of administering a therapeutically effective amount of p50, a peptide which is at least about 70% homologous to the p50 or an agent which up-regulates p50.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充